After finding some success in pressuring Deerfield, Illinois-based Walgreens not to invert, Sen. Dick Durbin has set his sights on another multinational in his home state.
The Senator sent a letter to the CEO of Lake Forest, Illinois-based Hospira on Aug. 14, urging them not to undergo a corporate inversion, according to The Chicago Tribune. An inversion is the process of acquiring a smaller, foreign company, merging the two companies and then using the opportunity to re-domicile abroad. This often allows companies to enjoy a significantly smaller tax burden and spend any money from foreign profits that it has held abroad in foreign subsidiaries.
“I strongly urge you and the Board of Directors not to duck your corporate responsibility by moving overseas to dodge paying U.S. taxes,” Durbin wrote in the letter to CEO Michael Ball, according to Crain’s Chicago Business. “A significant portion of Hospira’s revenue comes from U.S. taxpayers and depends on U.S. taxpayer-funded support.”
In discussing money from U.S. taxpayers, Durbin was referring to technologies purchased through taxpayer-supported programs, like injectable drugs and infusion tech, according to the news source. Programs like the Veterans Health Administration and Medicare have “contributed to Hospira’s corporate success.”
Some critics have accused Durbin and other Democrats of making corporate inversions an election issue in response to growing public awareness of and frustration with the practice. Crain’s Chicago Business also noted that, while Durbin appears to have been successful in blocking Walgreens from moving abroad by publicizing the issue, Hospira has less to lose in the game of public opinion, as it isn’t a consumer brand.
Durbin helped to introduce the “No Federal Contracts for Corporate Deserters Act” recently, which would bar companies that undergo an inversion from receiving federal defense contracts. Such a bill might be effective in some cases, but is unlikely to pass before the November election.
As tax attorneys I’ve analyzed the approach Senator Durbin has been taking in regards to corporate tax inversion. If you would like to read more, here are a few my previous posts on the subject.
If you purchase real property from a foreign person or entity, you may be required to withhold taxes from your payment to the seller under the Foreign Investment in Real Property Tax Act (FIRPTA). The federal tax law is designed to ensure that foreign sellers pay any applicable capital gains tax on profits realized from […]
Does Your Homeowners Insurance Provide Adequate Coverage?
Your home is likely your greatest asset, which is why it is so important to adequately protect it. Homeowners insurance protects you from the financial costs of unforeseen losses, such as theft, fire, and natural disasters, by helping you rebuild and replace possessions that were lost While the definition of “adequate” coverage depends upon a […]
Understanding the Importance of a Non-Contingent Offer
Making a non-contingent offer can dramatically increase your chances of securing a real estate transaction, particularly in competitive markets like New York City. However, buyers should understand that waiving contingencies, including those related to financing, or appraisals, also comes with significant risks. Determining your best strategy requires careful analysis of the property, the market, and […]
Fred D. Zemel Appointed Chair of Strategic Planning at Scarinci & Hollenbeck, LLC
Business Transactional Attorney Zemel to Spearhead Strategic Initiatives for Continued Growth and Innovation Little Falls, NJ – February 21, 2025 – Scarinci & Hollenbeck, LLC is pleased to announce that Partner Fred D. Zemel has been named Chair of the firm’s Strategic Planning Committee. In this role, Mr. Zemel will lead the committee in identifying, […]
Novation Agreement Process: Step-by-Step Guide for Businesses
Big changes sometimes occur during the life cycle of a contract. Cancelling a contract outright can be bad for your reputation and your bottom line. Businesses need to know how to best address a change in circumstances, while also protecting their legal rights. One option is to transfer the “benefits and the burdens” of a […]
What Is a Trade Secret? Key Elements and Legal Protections Explained
What is a trade secret and why you you protect them? Technology has made trade secret theft even easier and more prevalent. In fact, businesses lose billions of dollars every year due to trade secret theft committed by employees, competitors, and even foreign governments. But what is a trade secret? And how do you protect […]
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Sign up to get the latest from our attorneys!
Explore What Matters Most to You.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Sen. Dick Durbin Urges Hospira Not To Invert
Author: Scarinci Hollenbeck, LLC
After finding some success in pressuring Deerfield, Illinois-based Walgreens not to invert, Sen. Dick Durbin has set his sights on another multinational in his home state.
The Senator sent a letter to the CEO of Lake Forest, Illinois-based Hospira on Aug. 14, urging them not to undergo a corporate inversion, according to The Chicago Tribune. An inversion is the process of acquiring a smaller, foreign company, merging the two companies and then using the opportunity to re-domicile abroad. This often allows companies to enjoy a significantly smaller tax burden and spend any money from foreign profits that it has held abroad in foreign subsidiaries.
“I strongly urge you and the Board of Directors not to duck your corporate responsibility by moving overseas to dodge paying U.S. taxes,” Durbin wrote in the letter to CEO Michael Ball, according to Crain’s Chicago Business. “A significant portion of Hospira’s revenue comes from U.S. taxpayers and depends on U.S. taxpayer-funded support.”
In discussing money from U.S. taxpayers, Durbin was referring to technologies purchased through taxpayer-supported programs, like injectable drugs and infusion tech, according to the news source. Programs like the Veterans Health Administration and Medicare have “contributed to Hospira’s corporate success.”
Some critics have accused Durbin and other Democrats of making corporate inversions an election issue in response to growing public awareness of and frustration with the practice. Crain’s Chicago Business also noted that, while Durbin appears to have been successful in blocking Walgreens from moving abroad by publicizing the issue, Hospira has less to lose in the game of public opinion, as it isn’t a consumer brand.
Durbin helped to introduce the “No Federal Contracts for Corporate Deserters Act” recently, which would bar companies that undergo an inversion from receiving federal defense contracts. Such a bill might be effective in some cases, but is unlikely to pass before the November election.
As tax attorneys I’ve analyzed the approach Senator Durbin has been taking in regards to corporate tax inversion. If you would like to read more, here are a few my previous posts on the subject.
